Revenue Cycle Management Market - Global Forecast to 2020

The global revenue cycle management market is expected to reach USD 7.09 billion by 2020, at a CAGR of 11.8% from 2015 to 2020. Growing investments in healthcare IT and consolidation of healthcare providers are major factors influencing the growth of this market.

Revenue cycle management system (RCM) for healthcare providers enables healthcare organizations to accelerate their revenue cycles. This is achieved by reducing the number of denied insurance claims, speeding explanation of benefits (EOB) reconciliation, improving the quality of information, streamlining denial management, and automating processes. The RCM solution starts when a patient enters the hospital; it automates business processes leading to speedy follow ups, which encompasses patient and payer follow-ups. Hospitals need to maintain a faster RCM cycle to stay solvent, maintain requisite cash flow, and keep revenue figures stable.

The revenue cycle management market accounted for a share of 35.5% of the global healthcare provider IT market in 2014.

Revenue cycle management includes customer engagement, ranging from communication established with the service provider to the payment made by customers. Throughout the revenue cycle, the customer comes in contact with various aspects of the healthcare business. Revenue cycle management aids the process of making payments and reimbursements, based on the specified health plan that the patient holds. Case managers might be appointed to patients, who are assigned to look into the patient’s health status and payments. The patients are declared to have no balance in their respective accounts, if the government auditor or the insurance company doesn’t find errors.

The global revenue cycle management market is segmented on the basis of product type, component, deployment, end user, and geography. On the basis of geography, the market is classified into North America, Europe, Asia-Pacific, and rest of the world (RoW).

In 2014, North America accounted for the highest share in the global revenue cycle management market. As the growth of the healthcare industry is affected by healthcare expenditure, increased investments in healthcare IT solutions are expected to fuel the growth of the global revenue cycle management market in this region.

The report includes company profiles of major players, along with major developmental activities such as new product launches, mergers & acquisitions, collaborations, and partnerships. Companies profiled in this report include McKesson Corporation (U.S.), Cerner Corporation (U.S.), Quest Diagnostics (U.S.), Athenahealth, Inc. (U.S.), Allscripts (U.S.), eClinicalWorks (U.S.), CareCloud Corporation (U.S.), The SSI Groups, Inc. (U.S.), GE Healthcare (U.K.), Epic Systems (U.S.), Siemens Healthcare (Germany), and Kareo, Inc. (U.S.), among others.


Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis, namely, industry analysis (industry trends and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles. These comprise and discuss the basic views on competitive landscape, usage patterns, emerging- and high-growth segments, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities in the global revenue cycle management market.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help them garner a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies to strengthen their market share.

The report provides insights on the following pointers:
‧ Product Analysis and Development: Detailed insights on upcoming technologies, research and development activities, and new product launches in the global revenue cycle management market
‧ Market Development: Comprehensive information about lucrative emerging markets
‧ Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investment decisions in the global revenue cycle management market
‧ Competitive Assessment: In-depth assessment of market shares and company share analysis of key players in the market

TABLE OF CONTENTS

1 INTRODUCTION 22
1.1 OBJECTIVES OF THE STUDY 22
1.2 MARKET SEGMENTATION & COVERAGE 23
1.3 STAKEHOLDERS 23
2 RESEARCH METHODOLOGY 24
2.1 INTEGRATED ECOSYSTEM OF REVENUE CYCLE MANAGEMENT MARKET 24
2.2 ARRIVING AT THE REVENUE CYCLE MANAGEMENT MARKET SIZE 25
2.2.1 TOP-DOWN APPROACH 26
2.2.2 BOTTOM-UP APPROACH 27
2.2.3 MACRO INDICATOR-BASED APPROACH 28
2.3 ASSUMPTIONS 29
3 EXECUTIVE SUMMARY 30
4 MARKET OVERVIEW 32
4.1 INTRODUCTION 32
4.2 MARKET DRIVERS AND INHIBITORS 33
4.3 KEY MARKET DYNAMICS 34
5 REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT TYPE 36
5.1 INTRODUCTION 37
5.2 INTEGRATED 38
5.3 STANDALONE 39
6 REVENUE CYCLE MANAGEMENT MARKET, BY COMPONENT 40
6.1 INTRODUCTION 41
6.2 SERVICES 42
6.3 SOFTWARE 43
7 REVENUE CYCLE MANAGEMENT MARKET, BY DEPLOYMENT 44
7.1 INTRODUCTION 45
7.2 WEB-BASED 46
7.3 ON-PREMISE 47
7.4 CLOUD BASED 48
?
8 REVENUE CYCLE MANAGEMENT MARKET, BY END-USER 49
8.1 INTRODUCTION 50
8.2 HOSPITAL 51
8.3 PHYSICIANS 52
8.4 LABS 53
9 REVENUE CYCLE MANAGEMENT MARKET, BY GEOGRAPHY 54
9.1 NORTH AMERICA 55
9.1.1 BY PRODUCT TYPE 56
9.1.2 BY COMPONENT 57
9.1.3 BY DEPLOYMENT 58
9.1.4 BY END-USER 59
9.1.5 U.S. 60
9.1.5.1 BY PRODUCT TYPE 60
9.1.5.2 BY COMPONENT 61
9.1.5.3 BY DEPLOYMENT 62
9.1.5.4 BY END-USER 63
9.1.6 CANADA 64
9.1.6.1 BY PRODUCT TYPE 64
9.1.6.2 BY COMPONENT 65
9.1.6.3 BY DEPLOYMENT 66
9.1.6.4 BY END-USER 67
9.1.7 MEXICO 68
9.1.7.1 BY PRODUCT TYPE 69
9.1.7.2 BY COMPONENT 70
9.1.7.3 BY DEPLOYMENT 71
9.1.7.4 BY END-USER 72
9.2 EUROPE 73
9.2.1 BY PRODUCT TYPE 74
9.2.2 BY COMPONENT 75
9.2.3 BY DEPLOYMENT 76
9.2.4 BY END-USER 77
9.2.5 GERMANY 78
9.2.5.1 BY PRODUCT TYPE 79
9.2.5.2 BY COMPONENT 80
9.2.5.3 BY DEPLOYMENT 81
9.2.5.4 BY END-USER 82
9.2.6 U.K. 83
9.2.6.1 BY PRODUCT TYPE 84
9.2.6.2 BY COMPONENT 85
9.2.6.3 BY DEPLOYMENT 86
9.2.6.4 BY END-USER 87
9.2.7 FRANCE 88
9.2.7.1 BY PRODUCT TYPE 89
9.2.7.2 BY COMPONENT 90
9.2.7.3 BY DEPLOYMENT 91
9.2.7.4 BY END-USER 92
9.2.8 ITALY 93
9.2.8.1 BY PRODUCT TYPE 94
9.2.8.2 BY COMPONENT 95
9.2.8.3 BY DEPLOYMENT 96
9.2.8.4 BY END-USER 97
9.2.9 SPAIN 98
9.2.9.1 BY PRODUCT TYPE 99
9.2.9.2 BY COMPONENT 100
9.2.9.3 BY DEPLOYMENT 101
9.2.9.4 BY END-USER 102
9.2.10 REST OF EUROPE 103
9.2.10.1 BY PRODUCT TYPE 104
9.2.10.2 BY COMPONENT 105
9.2.10.3 BY DEPLOYMENT 106
9.2.10.4 BY END-USER 107
9.3 ASIA 108
9.3.1 BY PRODUCT TYPE 109
9.3.2 BY COMPONENT 110
9.3.3 BY DEPLOYMENT 111
9.3.4 BY END-USER 112
9.3.5 JAPAN 113
9.3.5.1 BY PRODUCT TYPE 114
9.3.5.2 BY COMPONENT 115
9.3.5.3 BY DEPLOYMENT 116
9.3.5.4 BY END-USER 117
9.3.6 CHINA 118
9.3.6.1 BY PRODUCT TYPE 119
9.3.6.2 BY COMPONENT 120
9.3.6.3 BY DEPLOYMENT 121
9.3.6.4 BY END-USER 122
9.3.7 INDIA 123
9.3.7.1 BY PRODUCT TYPE 124
9.3.7.2 BY COMPONENT 125
9.3.7.3 BY DEPLOYMENT 126
9.3.7.4 BY END-USER 127
9.3.8 REPUBLIC OF KOREA 128
9.3.8.1 BY PRODUCT 129
9.3.8.2 BY COMPONENT 130
9.3.8.3 BY DEPLOYMENT 131
9.3.8.4 BY END-USER 132
9.3.9 SINGAPORE 133
9.3.9.1 BY PRODUCT TYPE 134
9.3.9.2 BY COMPONENT 135
9.3.9.3 BY DEPLOYMENT 136
9.3.9.4 BY END-USER 137
9.4 REST OF THE WORLD(ROW) 138
9.4.1 BY PRODUCT TYPE 139
9.4.2 BY COMPONENT 140
9.4.3 BY DEPLOYMENT 141
9.4.4 BY END-USER 142
10 COMPETITIVE LANDSCAPE 143
10.1 COMPANY SHARE ANALYSIS 143
10.2 COMPANY PRESENCE IN THE REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT 144
10.3 MERGERS & ACQUISITIONS 145
10.4 EXPANSIONS 145
10.5 INVESTMENTS 146
10.6 JOINT VENTURES 146
11 COMPANY PROFILES 147
(Overview, Financials, Products & Services, Strategy, & Developments)*
11.1 ALLSCRIPTS 147
11.2 ATHENAHEALTH, INC. 150
11.3 CARECLOUD CORPORATION 153
11.4 CERNER CORPORATION 154
11.5 ECLINICALWORKS, LLC 159
11.6 EPIC SYSTEMS 161
11.7 GE HEALTHCARE 162
11.8 KAREO, INC. 165
11.9 MCKESSON CORPORATION 166
11.10 QUEST DIAGNOSTICS 170
11.11 THE SSI GROUP, INC. 173
11.12 CONIFER HEALTH SOLUTIONS, LLC (TH MEDICAL) 175
11.13 MEDASSETS, INC. 177
11.14 EMDEON INC 181
11.15 EXPERIAN PLC 184
11.16 TRANSUNION, LLC. 187
11.17 AJUBA INTERNATIONAL LLC. 189
11.18 COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION 190
11.19 ANTHELIO HEALTHCARE SOLUTIONS INC 192
11.20 MEDUSIND SOLUTIONS INC 194
11.21 SUTHERLAND HEALTHCARE SOLUTIONS 195
11.22 GENPACT LIMITED 197
11.23 GEBBS HEALTHCARE SOLUTIONS 199
11.24 OPTUM, INC. 201
11.25 OMEGA HEALTHCARE 203
*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.
12 APPENDIX 205
12.1 CUSTOMIZATION OPTIONS 205
12.1.1 REGULATORY FRAMEWORK 205
12.1.2 IMPACT ANALYSIS 205
12.2 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE 206
12.2.1 RT SNAPSHOTS 207
12.3 RELATED REPORTS 208